← Back to Search

Behavioral Intervention

Brain and Meditation (BAM) Study

N/A
Waitlist Available
Led By Dan Grupe, PhD
Research Sponsored by University of Wisconsin, Madison
Eligibility Criteria Checklist
Specific guidelines that determine who can or cannot participate in a clinical trial
Must have
Be older than 18 years old
Timeline
Screening 3 weeks
Treatment Varies
Follow Up baseline, following week 1, week 2, week 3, week 4 of intervention period, and 3 month follow-up
Awards & highlights
No Placebo-Only Group

Summary

This trial will test if an app-based meditation program can help reduce stress and its behavioral effects.

Who is the study for?
The BAM Study is for US citizens or permanent residents aged 25-65 who can understand English and are able to give informed consent. Participants must have a smartphone to download an app but should not be experienced in meditation practices, nor have current psychopathology that could affect participation.
What is being tested?
This study tests an app-based meditation program's effect on stress and behavior over 4-5 months. It's a randomized controlled trial, meaning people will be randomly assigned to either use the meditation program or not, to compare outcomes.
What are the potential side effects?
Since this trial involves mHealth Meditation via an app, there aren't typical medical side effects; however, participants may experience changes in mood or stress levels due to engaging with the meditation practices.

Timeline

Screening ~ 3 weeks
Treatment ~ Varies
Follow Up ~baseline, following week 1, week 2, week 3, week 4 of intervention period, and 3 month follow-up
This trial's timeline: 3 weeks for screening, Varies for treatment, and baseline, following week 1, week 2, week 3, week 4 of intervention period, and 3 month follow-up for reporting.

Treatment Details

Study Objectives

Study objectives can provide a clearer picture of what you can expect from a treatment.
Primary study objectives
Change in Perceived Stress Scale (PSS) Score
Secondary study objectives
Change in Behavioral Pattern Separation Task
Change in PROMIS Anxiety Score
Change in PROMIS Depression Score
Other study objectives
Change in Five-facet Mindfulness Questionnaire: Awareness Subscale (FFMQ-A8) Score
Change in Healthy Minds Index (HMI) Score
Change in NIH toolbox Loneliness Score
+3 more

Awards & Highlights

No Placebo-Only Group
All patients enrolled in this study will receive some form of active treatment.

Trial Design

2Treatment groups
Experimental Treatment
Active Control
Group I: Healthy Minds Program (HMP)Experimental Treatment1 Intervention
Fully remote, 4-week meditation intervention
Group II: Waitlist ControlActive Control1 Intervention
Control participants will not complete the Healthy Minds Program during the study, but can use it after they have completed the study

Find a Location

Logistics

Other reimbursement is provided

Other forms of reimbursement are provided for this trial.

Who is running the clinical trial?

University of Wisconsin, MadisonLead Sponsor
1,223 Previous Clinical Trials
3,167,978 Total Patients Enrolled
National Institute of Mental Health (NIMH)NIH
2,894 Previous Clinical Trials
2,731,615 Total Patients Enrolled
Dan Grupe, PhDPrincipal InvestigatorUniversity of Wisconsin, Madison

Media Library

Meditation Program (Behavioral Intervention) Clinical Trial Eligibility Overview. Trial Name: NCT05215314 — N/A
Stress Research Study Groups: Healthy Minds Program (HMP), Waitlist Control
Stress Clinical Trial 2023: Meditation Program Highlights & Side Effects. Trial Name: NCT05215314 — N/A
Meditation Program (Behavioral Intervention) 2023 Treatment Timeline for Medical Study. Trial Name: NCT05215314 — N/A
Stress Patient Testimony for trial: Trial Name: NCT05215314 — N/A
~43 spots leftby Oct 2025
Unbiased ResultsWe believe in providing patients with all the options.
Your Data Stays Your DataWe only share your information with the clinical trials you're trying to access.
Verified Trials OnlyAll of our trials are run by licensed doctors, researchers, and healthcare companies.
Back to top